Apyx Medical Net Worth

Apyx Medical Net Worth Breakdown

  APYX
The net worth of Apyx Medical is the difference between its total assets and liabilities. Apyx Medical's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Apyx Medical's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Apyx Medical's net worth can be used as a measure of its financial health and stability which can help investors to decide if Apyx Medical is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Apyx Medical stock.

Apyx Medical Net Worth Analysis

Apyx Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Apyx Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Apyx Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Apyx Medical's net worth analysis. One common approach is to calculate Apyx Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Apyx Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Apyx Medical's net worth. This approach calculates the present value of Apyx Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Apyx Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Apyx Medical's net worth. This involves comparing Apyx Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Apyx Medical's net worth relative to its peers.

Enterprise Value

66.4 Million

To determine if Apyx Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Apyx Medical's net worth research are outlined below:
Apyx Medical had very high historical volatility over the last 90 days
Apyx Medical may become a speculative penny stock
The company reported the previous year's revenue of 52.35 M. Net Loss for the year was (18.85 M) with profit before overhead, payroll, taxes, and interest of 29.13 M.
Apyx Medical currently holds about 20.06 M in cash with (5.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58.
Apyx Medical has a poor financial position based on the latest SEC disclosures
Roughly 16.0% of the company shares are held by company insiders
Latest headline from globenewswire.com: Apyx Medical Corporation Reports Third Quarter 2024 Financial ResultsUpdates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook

Apyx Medical Quarterly Good Will

185,000

Apyx Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Apyx Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Apyx Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
21st of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know Apyx Medical's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Apyx Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Apyx Medical backward and forwards among themselves. Apyx Medical's institutional investor refers to the entity that pools money to purchase Apyx Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Rathbone Brothers Plc2024-06-30
251.3 K
Perkins Capital Management Inc2024-09-30
217.5 K
Renaissance Technologies Corp2024-09-30
203.3 K
Bridgeway Capital Management, Llc2024-09-30
140.4 K
Kestra Advisory Services, Llc2024-06-30
124.2 K
Caption Management, Llc2024-09-30
115.5 K
State Street Corp2024-06-30
109.3 K
Dimensional Fund Advisors, Inc.2024-09-30
108.3 K
Northern Trust Corp2024-09-30
103.4 K
Archon Capital Management Llc2024-06-30
3.1 M
Royce & Associates, Lp2024-09-30
2.6 M
Note, although Apyx Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Apyx Medical's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 54.4 M.

Market Cap

66.74 Million

Project Apyx Medical's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.24)(0.22)
Return On Capital Employed(0.26)(0.25)
Return On Assets(0.24)(0.22)
Return On Equity(0.70)(0.67)
The company has Profit Margin (PM) of (0.58) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.46) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.46.
When accessing Apyx Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Apyx Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Apyx Medical's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Apyx Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Apyx Medical. Check Apyx Medical's Beneish M Score to see the likelihood of Apyx Medical's management manipulating its earnings.

Evaluate Apyx Medical's management efficiency

Apyx Medical has return on total asset (ROA) of (0.2183) % which means that it has lost $0.2183 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1025) %, meaning that it created substantial loss on money invested by shareholders. Apyx Medical's management efficiency ratios could be used to measure how well Apyx Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.22 in 2024. Return On Capital Employed is likely to rise to -0.25 in 2024. At this time, Apyx Medical's Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.8 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 8.2 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 0.78  0.76 
Tangible Book Value Per Share 0.78  0.66 
Enterprise Value Over EBITDA(4.72)(4.96)
Price Book Value Ratio 3.40  3.23 
Enterprise Value Multiple(4.72)(4.96)
Price Fair Value 3.40  3.23 
Enterprise Value100.9 M66.4 M
The strategic vision of Apyx Medical management plays a critical role in its financial performance. By evaluating this vision, we provide insights into the stock's growth potential.
Enterprise Value Revenue
1.3399
Revenue
49 M
Quarterly Revenue Growth
(0.10)
Revenue Per Share
1.415
Return On Equity
(1.10)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Apyx Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Apyx Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Apyx Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Todd Hornsby over a month ago
Acquisition by Todd Hornsby of 15000 shares of Apyx Medical at 1.77 subject to Rule 16b-3
 
Vizirgianakis Stavros G. over a month ago
Disposition of tradable shares by Vizirgianakis Stavros G. of Apyx Medical subject to Rule 16b-3
 
Swandal Craig A. over a month ago
Disposition of 7173 shares by Swandal Craig A. of Apyx Medical at 9.42 subject to Rule 16b-3
 
Moshe Citronowicz over three months ago
Acquisition by Moshe Citronowicz of 72000 shares of Apyx Medical at 10.96 subject to Rule 16b-3
 
Vizirgianakis Stavros G. over six months ago
Disposition of tradable shares by Vizirgianakis Stavros G. of Apyx Medical subject to Rule 16b-3
 
Lawrence Waldman over six months ago
Disposition of 8000 shares by Lawrence Waldman of Apyx Medical subject to Rule 16b-3
 
Baylor-henry Minnie over six months ago
Acquisition by Baylor-henry Minnie of 37000 shares of Apyx Medical at 10.28 subject to Rule 16b-3
 
Charles Goodwin over six months ago
Acquisition by Charles Goodwin of 9750 shares of Apyx Medical at 5.97 subject to Rule 16b-3
 
Renn Universal Growth Investment Trust over six months ago
Purchase by Renn Universal Growth Investment Trust of 7100 shares of Apyx Medical
 
Saron J Robert over a year ago
Sale by Saron J Robert of 13500 shares of Apyx Medical
 
Craig Swandal over a year ago
Acquisition by Craig Swandal of 17000 shares of Apyx Medical subject to Rule 16b-3
 
Lawrence Waldman over a year ago
Exercise or conversion by Lawrence Waldman of 5338 shares of Apyx Medical subject to Rule 16b-3
Apyx Medical time-series forecasting models is one of many Apyx Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Apyx Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Apyx Medical Earnings per Share Projection vs Actual

Apyx Medical Corporate Executives

Elected by the shareholders, the Apyx Medical's board of directors comprises two types of representatives: Apyx Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Apyx. The board's role is to monitor Apyx Medical's management team and ensure that shareholders' interests are well served. Apyx Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Apyx Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Tara SembTreasurer CFOProfile

Already Invested in Apyx Medical?

The danger of trading Apyx Medical is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Apyx Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Apyx Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Apyx Medical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.